Chemistry:5,N,N-TMT
From HandWiki
Short description: Chemical compound
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C13H18N2 |
| Molar mass | 202.301 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a psychedelic drug. It was first made in 1958 by Edwin H. P. Young.[1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency[2][3] which would suggest an active dosage for humans in the 20–60 mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.
Legal Status
United States
5,N,N-TMT is not scheduled at the federal level in the United States ,[4][5] but it could be considered an analog of 5-MeO-DMT, in which case, sales or possession intended for human consumption could be prosecuted under the Federal Analog Act.
See also
References
- ↑ "704. The synthesis of 5-hydroxytryptamine (serotonin) and related tryptamines.". Journal of the Chemical Society (Resumed): 3493–6. 1958. doi:10.1039/JR9580003493.
- ↑ "Serotonin receptor binding affinities of tryptamine analogues". Journal of Medicinal Chemistry 22 (4): 428–32. April 1979. doi:10.1021/jm00190a014. PMID 430481.
- ↑ "Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities". Psychopharmacology 68 (2): 155–8. 1980. doi:10.1007/BF00432133. PMID 6776558.
- ↑ "§ 1308.11 Schedule I.". http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_11.htm.
- ↑ "§ 1308.11 Schedule I.". 2022-02-17. https://www.ecfr.gov/current/title-21/chapter-II/part-1308.
 |  |
